A clinical trial to compare the effects of two chemotherapy regimens (vinflunine plus capecitabine versus capecitabine alone) in patients with advanced breast cancer.
Phase 3
Completed
- Registration Number
- CTRI/2009/091/000607
- Lead Sponsor
- Institut de Recherche Pierre Fabre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 764
Inclusion Criteria
1. Patients must give written informed consent
2. Women with confirmed carcinoma of the breast.
3. Patients must have received a minimum cumulative dose of anthracycline or be resistant to an anthracycline
4. Patients must be resistant to taxane therapy
Exclusion Criteria
1.Patients having received > 3 regimens of chemotherapy
2.Prior therapy with capecitabine and/or vinca alkaloids (including vinflunine).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method